Horizon Therapeutics Public Ltd Co

FIFTH THIRD BANCORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/31/2023

Shares

1,476

Value ($000)

171

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/31/2023	171	0.0%	1,476	9/30/2023
2023 Q2	7/26/2023	117	0.0%	1,138	6/30/2023
2023 Q1	4/24/2023	82	0.0%	749	3/31/2023
2022 Q4	1/25/2023	139	0.0%	1,224	12/31/2022
2022 Q3	10/25/2022	85	0.0%	1,369	9/30/2022
2022 Q2	8/4/2022	6,401	0.0%	80,252	6/30/2022
2022 Q1	4/19/2022	8,759	0.0%	83,249	3/31/2022
2021 Q4	2/1/2022	8,978	0.0%	83,317	12/31/2021
2021 Q3	10/15/2021	9,212	0.0%	84,101	9/30/2021
2021 Q2	8/6/2021	8,338	0.0%	89,047	6/30/2021
2021 Q1	5/7/2021	8,028	0.0%	87,228	3/31/2021
2020 Q4	2/16/2021	82	0.0%	1,117	12/31/2020
2020 Q3	11/9/2020	289	0.0%	3,721	9/30/2020
2020 Q2	8/5/2020	534	0.0%	9,613	6/30/2020
2020 Q1	5/5/2020	403	0.0%	13,612	3/31/2020
2019 Q4	2/14/2020	569	0.0%	15,709	12/31/2019